Anne Paulien Drenth
- Oncology top 10%
- Cancer Cells and Metastasis 4
- Cancer Research top 10%
- Cancer Genomics and Diagnostics 2
-
- Immune cells in cancer 2
-
- Epigenetics and DNA Methylation 3
- Genomics and Chromatin Dynamics 3
- Fibroblast Growth Factor Research 2
- CRISPR and Genetic Engineering 2
- Wnt/β-catenin signaling in development and cancer 2
- Co-authors
- Jos JonkersMartine H. van MiltenburgEva SchutSjors M. KasLinda HennemanLodewyk F.A. WesselsRenske de Korte‐GrimmerinkWilbert Zwart
- Cited by
- OncologyCancer ResearchImmunology
- Journals
- Nature (1 paper)Proceedings of the National Academy of Sciences (1 paper)Nature Communications (3 papers)
- Partner nations
- NetherlandsUnited KingdomAustralia
In The Last Decade
Anne Paulien Drenth
12 papers receiving 833 citations
Hit Papers
Peers
Comparison fields: 5 of 76
- Oncology 431
- Cancer Research 185
- Immunology 197
- Molecular Biology 482
- Biotechnology 31
Countries citing papers authored by Anne Paulien Drenth
This map shows the geographic impact of Anne Paulien Drenth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Paulien Drenth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Paulien Drenth more than expected).
Fields of papers citing papers by Anne Paulien Drenth
This network shows the impact of papers produced by Anne Paulien Drenth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Paulien Drenth. The network helps show where Anne Paulien Drenth may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Anne Paulien Drenth, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 10 | |
| 3 | 2023 | 63 | |
| 4 | 2020 | 7 | |
| 5 | 2019 | 54 | |
| 6 | 2019 | 23 | |
| 7 | 2019 | 3 | |
| 8 | Loss of p53 triggers WNT-dependent systemic inflammation to drive breast cancer metastasisbreakdown → | 2019 | 361 |
| 9 | 2019 | 37 | |
| 10 | 2018 | 30 | |
| 11 | 2017 | 55 | |
| 12 | 2016 | 100 | |
| 13 | 2015 | 95 |
About Anne Paulien Drenth
Anne Paulien Drenth is a scholar working on Oncology, Immunology and Allergy and Molecular Biology, having authored 13 papers that have together received 838 indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (4 papers), Epigenetics and DNA Methylation (3 papers), Genomics and Chromatin Dynamics (3 papers), Fibroblast Growth Factor Research (2 papers), CRISPR and Genetic Engineering (2 papers), Immune cells in cancer (2 papers), Cancer Genomics and Diagnostics (2 papers) and Wnt/β-catenin signaling in development and cancer (2 papers). The work is most often cited by research in Oncology (431 citations), Cancer Research (185 citations) and Immunology (197 citations). Anne Paulien Drenth has collaborated with scholars based in Netherlands, United Kingdom and Australia. Frequent co-authors include Jos Jonkers, Martine H. van Miltenburg, Eva Schut, Sjors M. Kas, Linda Henneman, Lodewyk F.A. Wessels, Renske de Korte‐Grimmerink, Wilbert Zwart, Iris de Rink and Eline van der Burg. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.